![PDF) Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-γ PDF) Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-γ](https://i1.rgstatic.net/publication/12965030_Troglitazone_an_antidiabetic_agent_inhibits_cholesterol_biosynthesis_through_a_mechanism_independent_of_peroxisome_proliferator-activated_receptor-g/links/0fcfd50e48acbc3558000000/largepreview.png)
PDF) Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-γ
![PDF) Prevalence of patients reaching the targets of good control in normal clinical practice - A cohort-based study in type 2 diabetes PDF) Prevalence of patients reaching the targets of good control in normal clinical practice - A cohort-based study in type 2 diabetes](https://i1.rgstatic.net/publication/12713174_Prevalence_of_patients_reaching_the_targets_of_good_control_in_normal_clinical_practice_-_A_cohort-based_study_in_type_2_diabetes/links/53eb3f1b0cf28f342f45238c/largepreview.png)
PDF) Prevalence of patients reaching the targets of good control in normal clinical practice - A cohort-based study in type 2 diabetes
![PDF) Evolutionary Changes of Astroglia in Elasmobranchii Comparing to Amniotes: A Study Based on Three Immunohistochemical Markers (GFAP, S-100, and Glutamine Synthetase) PDF) Evolutionary Changes of Astroglia in Elasmobranchii Comparing to Amniotes: A Study Based on Three Immunohistochemical Markers (GFAP, S-100, and Glutamine Synthetase)](https://www.researchgate.net/profile/Csilla-Ari/publication/5406482/figure/tbl1/AS:667121507901453@1536065570353/The-most-characteristic-glial-features-of-certain-brain-areas-based-on_Q320.jpg)
PDF) Evolutionary Changes of Astroglia in Elasmobranchii Comparing to Amniotes: A Study Based on Three Immunohistochemical Markers (GFAP, S-100, and Glutamine Synthetase)
![PDF) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas PDF) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas](https://www.researchgate.net/profile/Tetsuo-Shoji-2/publication/12965418/figure/fig2/AS:601580541841417@1520439386119/figure-fig2_Q320.jpg)
PDF) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas
![PDF) A case of hepatocyte nuclear factor-1α diabetes/MODY3 masquerading as Type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea PDF) A case of hepatocyte nuclear factor-1α diabetes/MODY3 masquerading as Type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea](https://i1.rgstatic.net/publication/12965439_A_case_of_hepatocyte_nuclear_factor-1a_diabetesMODY3_masquerading_as_Type_1_diabetes_in_a_Mexican-American_adolescent_and_responsive_to_a_low_dose_of_sulfonylurea/links/543fb7ed0cf21227a11afbeb/largepreview.png)
PDF) A case of hepatocyte nuclear factor-1α diabetes/MODY3 masquerading as Type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea
![PDF) In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed PDF) In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed](https://www.researchgate.net/profile/Robert-Anderson-49/publication/12713173/figure/fig1/AS:667214457888802@1536087731608/Progression-from-IGT-to-diabetes-in-the-subjects-with-2-h-plasma-glucose-above-or-below_Q320.jpg)